5ΜM CPT
BACKGROUND PLASMA MEMBRANE MICROPARTICLE
CD105
CD59
CD59
CPT
CPT
CPT
CPT
CPT
CPT
CPT
CPT ANALOGUE
TREATED HUVEC CULTURE CPT
CPT TREATMENT
DMSO
DMSO
DMSO
TREATED HUVEC DMSO
DNA-FRAGMENTATION
DNA-FRAGMENTATION
ENDOTHELIAL ANTIGEN
FSC
FSC
FLOW CYTOMETRY ANALYSIS
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUVEC MP COUNT
HUVEC CULTURE
HUVEC CULTURE
REACHING CONFLUENCE HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUVEC STIMULATED
LIPOPOLYSACCHARIDE
LIVING CELL
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MP COUNT
MP DETECTION
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE INDUCED
NIH
PHOSPHATIDYLSERINE
PHOSPHATIDYLSERINE
PHOSPHATIDYLSERINE
PS-CONTAINING MEMBRANE MP
PS-EXPOSING MP
PLASMA MEMBRANE BLEBBING
PROAPOPTOTIC
SSC
SIMILAR SHORT-TIME ACTIVATION
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL SIMILAR SHORT-TIME ACTIVATION
TNFΑ
TUNEL
TUNEL-POSITIVITY
USING FLOW CYTOMETRY
ZVAD
ZVAD
ACTIVATING PEPTIDE
ADHERENT CELL
ADHERENT CELL
AFFINITY
PHOSPHATIDYLSERINE AFFINITY
AGONIST
AGONIST
AGONIST
ANALYZED MP
ANNEXIN
ANNEXIN
ANNEXIN V-FITC
ANNEXIN V-BINDING
ANNEXIN V-BINDING
ANNEXIN V-BINDING MP
ANNEXIN V-BINDING MP
ANNEXIN V-BINDING MP
ANNEXIN V-BINDING MEMBRANE
ANNEXIN V-BINDING MICROPARTICLE
ANTICOAGULANT FUNCTION
ANTINEOPLASTIC AGENT
APOPTOSI
APOPTOSI
APOPTOSI
ADHERENT CELL APOPTOSI
APOPTOTIC T-LYMPHOCYTE
APOPTOTIC BODY
APOPTOTIC CELL
BLOOD PLATELET
CALPAIN-DEPENDENT DISSOCIATION
CAMPTOTHECIN
CAMPTOTHECIN PHASE CONTRAST MICROSCOPY
CATALYTIC SURFACE
CELL APOPTOSI
CELL APOPTOSI
CELL DESQUAMATION
CELL SUPERNATANT
CELLULAR ACTIVATION
CELLULAR ORIGIN
CHEMOTACTIC PEPTIDE FMLP
CIRCULATING MP
CIRCULATING MP
COLLAGEN
COMPLEMENT
CONCENTRATION
CONCENTRATION
CONCENTRATION
CPT CONCENTRATION
CPT CONCENTRATION
IONOPHORE CONCENTRATION
CONFLUENCE
CONFLUENCE
CONTROL CELL
CONTROL CULTURE
CORONARY SYNDROME
CULTURE MATURATION
CYCLOHEXIMIDE
CYCLOHEXIMIDE TREATMENT
DETERMINANT
PHAGOCYTE RECOGNITION DETERMINANT
DIAGNOSTIC MARKER
VESSEL WALL INJURY DIAGNOSTIC MARKER
ENDOTHELIAL MP
ENDOTHELIAL ANTIGEN
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL INJURY
ENDOTHELIAL ORIGIN
ENDOTOXIN-STIMULATED MONOCYTE
FLOW CYTOMETRY
HOMOGENEOUS POPULATION
HR
HR
HR
HR
HR
HR
HR
HR
HR
HRS INCUBATION
INDUCED MP-RELEASE
INDUCTION
APOPTOSI INDUCTION
INHIBITOR CAMPTOTHECIN
IONOPHORE
LIVING CELL
LUPUS ANTICOAGULANT
MATURATION
MEMBRANE MP
MEMBRANE MICROPARTICLE
MEMBRANE VESICULATION
MICROPARTICLE
FLOW CYTOMETRY ANALYSIS MICROPARTICLE
MIN TREATMENT
MORPHOLOGICAL CHANGE
NM
NM CPT
NM CPT
NM CAMPTOTHECIN
INDUCED MP-RELEASE NM CAMPTOTHECIN
NECROTIC CELL
NORMAL HUMAN BLOOD
NORMAL RESTRICTION
PHOSPHATIDYLSERINE NORMAL RESTRICTION
PATHOPHYSIOLOGICAL ROLE
CIRCULATING MP PATHOPHYSIOLOGICAL ROLE
PHAGOCYTE RECOGNITION
PHORBOL MYRISTATE ACETATE
PHOSPHATIDYLSERINE
PHOSPHOLIPID-BINDING PROTEIN
PLASMA COUNT
ENDOTHELIAL MP PLASMA COUNT
PLATELET PROTEIN KINAS
PLATELET
PLATELETS STIMULATED
POLYMORPHONUCLEAR LEUCOCYTE
PROAPOPTOTIC STIMULATION
PROPIDIUM IODIDE
PROPIDIUM IODIDE
PROPIDIUM IODIDE ASSAY
PROTEIN C
PROTHROMBINASE COMPLEX
RAPID STIMULATION
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL RAPID STIMULATION
REACHING CONFLUENCE
REMAINING ADHERENT
SPONTANEOUS APOPTOSI
SUBCONFLUENT HUVEC
SUBMEMBRANE CYTOSKELETON
THROMBIN
THROMBIN
THROMBIN
THROMBIN RECEPTOR
ACTIVATING PEPTIDE THROMBIN RECEPTOR
THROMBOTIC THROMBOCYTOPENIC PURPURA
TISSUE PLASMINOGEN ACTIVATOR
TOPOISOMERASE I
TOPOISOMERASE I
INHIBITOR CAMPTOTHECIN TOPOISOMERASE I
TREATED HUVEC
TREATED HUVEC CULTURE
UMBILICAL VEIN ENDOTHELIAL CELL
UNSTIMULATED CELL CULTURE
UNSTIMULATED CELL
VESSEL WALL INJURY
ΜM
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT TREATMENT
ΜM IONOPHORE
ΜG/ML
ΜG/ML
ΜG/ML
ΜM
ΜMOL/L
ΜMOL/L
MICROPARTICLES
MP
PS
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUVEC
PMA
THROMBIN RECEPTOR ACTIVATING PEPTIDE
TRAP
THR
TPA
ANGIOTENSIN II
AGTII
CPT
treatments
FLOW CYTOMETRY
CYTOMETRY ANALYSIS
cytometry
MP COUNT
MP
counts
detection
MP-RELEASE
MEMBRANE MP
MP
membrane blebbing
SHORT-TIME ACTIVATION
FLOW CYTOMETRY
peptides
adherent
adherent
MP
ANNEXIN
V-BINDING MP
V-BINDING MP
V-BINDING MP
functions
dissociation
DESQUAMATION
activation
origins
PEPTIDE FMLP
peptides
MP
MP
controls
controls
MATURATION
treatments
markers
MP
injury
origins
ENDOTOXIN-STIMULATED
cytometry
populations
INCUBATION
MP-RELEASE
inhibitors
CAMPTOTHECIN
anticoagulant
MP
VESICULATION
min
treatments
CPT
CPT
CAMPTOTHECIN
restrictions
RECOGNITION
myristate
PLATELET PROTEIN
polymorphonuclear
STIMULATION
propidium
IODIDE
propidium
IODIDE
PROPIDIUM IODIDE
propidium
IODIDE
STIMULATION
CONFLUENCE
adherent
HUVEC
cytoskeleton
THROMBIN
receptors
THROMBOCYTOPENIC PURPURA
plasminogen activator
plasminogen
topoisomerases
topoisomerases
HUVEC
TREATED HUVEC
HUVEC
endothelial
UNSTIMULATED CELL
vessels
WALL INJURY
CPT
CPT
CPT
CPT
CPT
ΜM CPT
CPT TREATMENT
CPT
IONOPHORE
